US Stock MarketDetailed Quotes

BPMC Blueprint Medicines

Watchlist
  • 105.550
  • -0.840-0.79%
Close Jun 14 16:00 ET
  • 105.550
  • 0.0000.00%
Post 17:31 ET
6.61BMarket Cap-21898P/E (TTM)

Blueprint Medicines Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
51.87%96.12M
22.22%249.38M
85.55%71.96M
-14.26%56.57M
57.52%57.57M
0.89%63.29M
13.30%204.04M
-63.76%38.78M
172.77%65.98M
33.90%36.55M
Operating revenue
51.87%96.12M
22.22%249.38M
85.55%71.96M
-14.26%56.57M
57.52%57.57M
0.89%63.29M
13.30%204.04M
-63.76%38.78M
172.77%65.98M
33.90%36.55M
Cost of revenue
0.50%3.19M
-52.06%8.54M
-94.64%260K
-7.27%2.78M
-52.46%2.32M
-37.49%3.18M
-0.67%17.81M
-35.78%4.85M
-20.84%3M
-24.75%4.89M
Gross profit
54.59%92.93M
29.33%240.84M
111.29%71.7M
-14.60%53.78M
74.50%55.25M
4.27%60.11M
14.85%186.22M
-65.89%33.93M
208.74%62.98M
52.20%31.66M
Operating expense
-6.16%171.75M
1.13%722.86M
-2.75%176.85M
-2.48%180.99M
-2.76%181.99M
14.25%183.02M
-10.24%714.79M
-55.76%181.86M
38.27%185.59M
44.73%187.15M
Selling and administrative expenses
17.77%83.56M
24.34%295.14M
23.89%79.32M
22.80%70.74M
22.57%71.93M
24.35%70.95M
21.55%237.37M
18.12%64.02M
15.66%57.61M
19.08%58.69M
-Selling and marketing expense
68.46%16.93M
----
----
69.34%13.07M
18.10%11.37M
--10.05M
----
----
--7.72M
--9.63M
-General and administrative expense
9.40%66.63M
----
----
15.60%57.67M
23.44%60.56M
--60.9M
----
----
--49.89M
--49.06M
Research and development costs
-21.31%88.19M
-10.41%427.72M
-17.23%97.54M
-13.85%110.25M
-14.33%110.06M
8.67%112.07M
-20.57%477.42M
-66.98%117.84M
51.60%127.98M
60.53%128.47M
Operating profit
35.87%-78.82M
8.81%-482.02M
28.91%-105.15M
-3.75%-127.21M
18.49%-126.75M
-19.87%-122.91M
16.65%-528.57M
52.53%-147.93M
-7.72%-122.61M
-43.30%-155.49M
Net non-operating interest income expense
-1.31%-5.9M
-12.08%-18.79M
44.06%-5.17M
54.65%-3.81M
-1,035.83%-4M
-1,416.52%-5.82M
-802.72%-16.77M
-2,095.68%-9.24M
-1,621.01%-8.4M
-32.54%427K
Non-operating interest income
55.56%9.18M
----
----
216.24%9.33M
1,689.61%7.75M
--5.9M
----
----
--2.95M
-31.60%433K
Non-operating interest expense
28.62%15.07M
----
----
15.79%13.14M
195,650.00%11.75M
--11.72M
----
----
--11.35M
--6K
Total other finance cost
----
12.08%18.79M
----
----
----
----
802.72%16.77M
----
----
----
Other net income (expense)
56,240.00%174.03M
25.09%-5.2M
-20.09%-532K
-96.93%-2.5M
-22.93%-1.86M
91.66%-310K
25.25%-6.94M
90.98%-443K
66.53%-1.27M
-305.63%-1.51M
Earnings from equity interest
--0
52.44%-4.26M
102.40%45K
-6.37%-1.77M
42.47%-1.23M
60.31%-1.3M
-14.70%-8.95M
58.69%-1.87M
49.07%-1.67M
---2.15M
Special income (charges)
--173.66M
----
----
----
----
--0
----
----
----
----
-Less:Other special charges
---173.66M
----
----
----
----
----
----
----
----
----
Other non- operating income (expenses)
-61.87%376K
-147.21%-946K
-140.38%-577K
-283.84%-728K
-199.05%-626K
317.66%986K
234.59%2M
476.05%1.43M
175.86%396K
269.44%632K
Income before tax
169.22%89.32M
8.38%-506.02M
29.66%-110.86M
-0.94%-133.52M
15.31%-132.6M
-21.95%-129.04M
13.85%-552.28M
50.13%-157.61M
-12.99%-132.28M
-44.64%-156.58M
Income tax
-65.38%180K
-81.51%968K
-94.11%61K
-77.77%197K
-93.93%190K
182.61%520K
74.48%5.24M
-60.65%1.04M
406.29%886K
1,521.76%3.13M
Net income
168.80%89.14M
9.06%-506.98M
30.09%-110.92M
-0.41%-133.71M
16.85%-132.79M
-22.23%-129.56M
13.44%-557.52M
50.22%-158.65M
-13.58%-133.16M
-47.27%-159.71M
Net income continuous Operations
168.80%89.14M
9.06%-506.98M
30.09%-110.92M
-0.41%-133.71M
16.85%-132.79M
-22.23%-129.56M
13.44%-557.52M
50.22%-158.65M
-13.58%-133.16M
-47.27%-159.71M
Minority interest income
Net income attributable to the parent company
168.80%89.14M
9.06%-506.98M
30.09%-110.92M
-0.41%-133.71M
16.85%-132.79M
-22.23%-129.56M
13.44%-557.52M
50.22%-158.65M
-13.58%-133.16M
-47.27%-159.71M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
168.80%89.14M
9.06%-506.98M
30.09%-110.92M
-0.41%-133.71M
16.85%-132.79M
-22.23%-129.56M
13.44%-557.52M
50.22%-158.65M
-13.58%-133.16M
-47.27%-159.71M
Basic earnings per share
167.44%1.45
10.48%-8.37
31.32%-1.82
1.35%-2.2
18.28%-2.19
-20.11%-2.15
15.08%-9.35
50.93%-2.65
-11.50%-2.23
-44.09%-2.68
Diluted earnings per share
165.12%1.4
10.48%-8.37
31.32%-1.82
1.35%-2.2
18.28%-2.19
-20.11%-2.15
15.08%-9.35
50.93%-2.65
-11.50%-2.23
-44.09%-2.68
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 51.87%96.12M22.22%249.38M85.55%71.96M-14.26%56.57M57.52%57.57M0.89%63.29M13.30%204.04M-63.76%38.78M172.77%65.98M33.90%36.55M
Operating revenue 51.87%96.12M22.22%249.38M85.55%71.96M-14.26%56.57M57.52%57.57M0.89%63.29M13.30%204.04M-63.76%38.78M172.77%65.98M33.90%36.55M
Cost of revenue 0.50%3.19M-52.06%8.54M-94.64%260K-7.27%2.78M-52.46%2.32M-37.49%3.18M-0.67%17.81M-35.78%4.85M-20.84%3M-24.75%4.89M
Gross profit 54.59%92.93M29.33%240.84M111.29%71.7M-14.60%53.78M74.50%55.25M4.27%60.11M14.85%186.22M-65.89%33.93M208.74%62.98M52.20%31.66M
Operating expense -6.16%171.75M1.13%722.86M-2.75%176.85M-2.48%180.99M-2.76%181.99M14.25%183.02M-10.24%714.79M-55.76%181.86M38.27%185.59M44.73%187.15M
Selling and administrative expenses 17.77%83.56M24.34%295.14M23.89%79.32M22.80%70.74M22.57%71.93M24.35%70.95M21.55%237.37M18.12%64.02M15.66%57.61M19.08%58.69M
-Selling and marketing expense 68.46%16.93M--------69.34%13.07M18.10%11.37M--10.05M----------7.72M--9.63M
-General and administrative expense 9.40%66.63M--------15.60%57.67M23.44%60.56M--60.9M----------49.89M--49.06M
Research and development costs -21.31%88.19M-10.41%427.72M-17.23%97.54M-13.85%110.25M-14.33%110.06M8.67%112.07M-20.57%477.42M-66.98%117.84M51.60%127.98M60.53%128.47M
Operating profit 35.87%-78.82M8.81%-482.02M28.91%-105.15M-3.75%-127.21M18.49%-126.75M-19.87%-122.91M16.65%-528.57M52.53%-147.93M-7.72%-122.61M-43.30%-155.49M
Net non-operating interest income expense -1.31%-5.9M-12.08%-18.79M44.06%-5.17M54.65%-3.81M-1,035.83%-4M-1,416.52%-5.82M-802.72%-16.77M-2,095.68%-9.24M-1,621.01%-8.4M-32.54%427K
Non-operating interest income 55.56%9.18M--------216.24%9.33M1,689.61%7.75M--5.9M----------2.95M-31.60%433K
Non-operating interest expense 28.62%15.07M--------15.79%13.14M195,650.00%11.75M--11.72M----------11.35M--6K
Total other finance cost ----12.08%18.79M----------------802.72%16.77M------------
Other net income (expense) 56,240.00%174.03M25.09%-5.2M-20.09%-532K-96.93%-2.5M-22.93%-1.86M91.66%-310K25.25%-6.94M90.98%-443K66.53%-1.27M-305.63%-1.51M
Earnings from equity interest --052.44%-4.26M102.40%45K-6.37%-1.77M42.47%-1.23M60.31%-1.3M-14.70%-8.95M58.69%-1.87M49.07%-1.67M---2.15M
Special income (charges) --173.66M------------------0----------------
-Less:Other special charges ---173.66M------------------------------------
Other non- operating income (expenses) -61.87%376K-147.21%-946K-140.38%-577K-283.84%-728K-199.05%-626K317.66%986K234.59%2M476.05%1.43M175.86%396K269.44%632K
Income before tax 169.22%89.32M8.38%-506.02M29.66%-110.86M-0.94%-133.52M15.31%-132.6M-21.95%-129.04M13.85%-552.28M50.13%-157.61M-12.99%-132.28M-44.64%-156.58M
Income tax -65.38%180K-81.51%968K-94.11%61K-77.77%197K-93.93%190K182.61%520K74.48%5.24M-60.65%1.04M406.29%886K1,521.76%3.13M
Net income 168.80%89.14M9.06%-506.98M30.09%-110.92M-0.41%-133.71M16.85%-132.79M-22.23%-129.56M13.44%-557.52M50.22%-158.65M-13.58%-133.16M-47.27%-159.71M
Net income continuous Operations 168.80%89.14M9.06%-506.98M30.09%-110.92M-0.41%-133.71M16.85%-132.79M-22.23%-129.56M13.44%-557.52M50.22%-158.65M-13.58%-133.16M-47.27%-159.71M
Minority interest income
Net income attributable to the parent company 168.80%89.14M9.06%-506.98M30.09%-110.92M-0.41%-133.71M16.85%-132.79M-22.23%-129.56M13.44%-557.52M50.22%-158.65M-13.58%-133.16M-47.27%-159.71M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 168.80%89.14M9.06%-506.98M30.09%-110.92M-0.41%-133.71M16.85%-132.79M-22.23%-129.56M13.44%-557.52M50.22%-158.65M-13.58%-133.16M-47.27%-159.71M
Basic earnings per share 167.44%1.4510.48%-8.3731.32%-1.821.35%-2.218.28%-2.19-20.11%-2.1515.08%-9.3550.93%-2.65-11.50%-2.23-44.09%-2.68
Diluted earnings per share 165.12%1.410.48%-8.3731.32%-1.821.35%-2.218.28%-2.19-20.11%-2.1515.08%-9.3550.93%-2.65-11.50%-2.23-44.09%-2.68
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg
Concept Cancer Research
Cancer Research
Intraday+0.08%